The shares of Aurobindo Pharma ended 2.7% in the red, but off intra-day lows, in the session on Wednesday, February 14. The shares snapped a four-day gaining streak, and has now fallen in six out of the last 10 trading sessions. Dealer suggest that a clutch of domestic Mutual Funds were active buyers today.
Sensex, Nifty 50 Stage Sharp Intraday Recovery
The Indian equity benchmarks Sensex, Nifty 50 staged sharp intraday recovery on Wednesday and ended at the day's high. BSE Sensex settled 278 points higher, while Nifty 50 ended above the 21,800 mark. SBI and Reliance were the top Nifty contributors, lifting the index by 52 points. The Nifty Bank index gained over 400 points.
Oil Manufacturing Companies and PSU banks were buzzing in trade today, PSUs were back in focus. Overall the flows were mixed at the institutional desk.
Tech stocks were under pressure on the back of weak global cues.
The range for Nifty is now seen between 21,690 -21,850 levels.
Besides Aurobindo Pharma, these stocks also made it to the dealing room chatter today:
Swan Energy: The shares of Swan Energy ended 1.7% higher today, up for second day in a row, not far from 52-week high of ₹722.2 apiece hit earlier in the session. Sources in the dealing room tell CNBC-TV18 that a large fund raise is likely to happen soon.
Macrotech Developers: The shares of the realty company ended 4.5% higher, up for second day in a row. According to dealers, there were strong buy flows at the FII desk and high delivery volumes are expected.
Vedanta: The shares of the natural resources company ended close to 5% higher, in the green for second day in a row. Street expects a large block deal soon.
(Edited by : Asmita Pant)